Day: April 28, 2025

Purple Biotech Reports Positive NT219 Data at AACR for Colorectal and Head and Neck Cancers

Written by Customer Service on April 28, 2025. Posted in Public Companies.

Activated b-catenin or loss of its negative regulator adenomatous polyposis coli (APC) is a potential biomarker for NT219 in the treatment of colorectal cancer NT219’s mechanism of action informs how it can restore efficacy of immunotherapies and expand the patient population that can benefit from immunotherapiesREHOVOT, Israel, April 28, 2025 (GLOBE NEWSWIRE) — Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, announced today that two posters reporting new NT219 data being presented at the American Association for Cancer Research (AACR 2025) Annual Meeting on Sunday and Monday, April 27-28, 2025. NT219, a novel dual inhibitor of IRS1/2 and STAT3, is...

Recursion to Report First Quarter 2025 Business Updates and Financial Results on May 5th

Written by Customer Service on April 28, 2025. Posted in Earnings Releases And Operating Results.

Company to host public (L)earnings call on May 5th at 8:00 am ET / 6:00 am MT / 1:00 pm GMT Salt Lake City, UT, April 28, 2025 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its first quarter 2025 financial results on Monday, May 5, 2025, before the open of the financial markets. Recursion will host a (L)earnings Call on May 5, 2025 at 8:00 am ET / 6:00 am MT / 1:00 pm GMT. The company will broadcast the live stream from Recursion’s X (formerly Twitter), LinkedIn, and YouTube accounts. Investors, analysts, and the public will be able to ask questions of the company by submitting questions here: https://forms.gle/LYZwaVdPJidC7x259. About RecursionRecursion (NASDAQ: RXRX) is a clinical stage...

Pluri Completes Strategic Acquisition of Leading Cultivated Cacao AgFoodTech Company, Kokomodo Ltd.

Written by Customer Service on April 28, 2025. Posted in Mergers And Acquisitions.

Acquisition of approximately 71% stake in Kokomodo Ltd. Acquisition uniquely combines Pluri’s mass-scale cell production expertise with Kokomodo Ltd.’s ability to craft real, controlled, climate-resilient cacao using cellular agriculture technologyHAIFA, Israel, April 28, 2025 (GLOBE NEWSWIRE) — Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a leading biotechnology company leveraging its proprietary platform for cell-based solutions to create a collaborative network of ventures, today announced the completion of the acquisition of approximately 71% of the equity of Kokomodo Ltd. (“Kokomodo”), an innovative AgFoodTech company specializing in cultivated cacao production, for $4.5 million payable in 976,139 of the Company’s Common Shares (the “Common Shares” and the “Kokomodo Transaction”, respectively)....

LifeMD Acquires Women’s Health Provider Optimal Human Health MD to Accelerate Entry into the Women’s Health Market

Written by Customer Service on April 28, 2025. Posted in Mergers And Acquisitions.

Acquisition Establishes Clinical and Operational Foundation for LifeMD’s Comprehensive Women’s Health Offering, Launching Summer 2025 NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) — LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the acquisition of key assets from Optimal Human Health MD (“Optimal”), a nationwide women’s health virtual care provider. This strategic acquisition marks LifeMD’s official entry into the women’s health market and establishes a scalable clinical foundation for a comprehensive virtual health program under the LifeMD brand, focused on hormone health, bone density, metabolism, and long-term wellness. With women’s health historically underserved—particularly in areas such as perimenopause, menopause, and hormonal balance—LifeMD’s expansion addresses a significant...

Franklin Electric Declares Quarterly Dividend of $0.265 Per Share

Written by Customer Service on April 28, 2025. Posted in Dividend Reports And Estimates.

FORT WAYNE, Ind., April 28, 2025 (GLOBE NEWSWIRE) — Franklin Electric Co., Inc. (NASDAQ: FELE) announced today that its Board of Directors declared a quarterly cash dividend of $0.265 per share payable May 22, 2025, to shareholders of record on May 8, 2025. About Franklin ElectricFranklin Electric is a global leader in the production and marketing of systems and components for the movement of water and energy. Recognized as a technical leader in its products and services, Franklin Electric serves customers around the world in residential, commercial, agricultural, industrial, municipal, and fueling applications. Franklin Electric is proud to be named in Newsweek’s lists of America’s Most Responsible Companies and Most Trustworthy Companies for 2024 and America’s Climate Leaders 2024 by USA Today. “Safe Harbor” Statement under the...

Heritage Distilling Co. Reports Full Year 2024 Financial Results

Written by Customer Service on April 28, 2025. Posted in Earnings Releases And Operating Results.

Company achieves EBITDA exceeding $4.5 million and profitability with net income exceeding $0.7 million, or $0.05 per share, for full year 2024 Heritage reported Q4 2024 topline revenue increased 26.4% versus Q4 2023, eclipsing $3 million Heritage reported 5.4% year over year revenue growth GIG HARBOR, Wash., April 28, 2025 (GLOBE NEWSWIRE) — Heritage Distilling Company, Inc. (“HDC” or “Heritage” or the “Company”) (Nasdaq: CASK), a leading craft distiller of innovative premium brands, today reported its full year 2024 financial results for the twelve-month period ended December 31, 2024. “2024 was a transformative year for Heritage. We successfully transitioned from a private company to a publicly traded company with our IPO in November, marking our debut on Nasdaq. This move strengthened our balance sheet,...

Bright Minds Biosciences to Host Virtual R&D Day on May 20, 2025; Program Highlights Include an Overview of Absence Seizures and the BMB-101 Phase 2 Study

Written by Customer Service on April 28, 2025. Posted in Public Companies.

VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) — Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”), a company focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, depression, and other central nervous system (CNS) disorders, today announced that it will host a virtual R&D Day on Tuesday, May 20, 2025, from 10:00 am – 11:30 am ET. The event will provide an overview of absence seizures and will focus on the unmet need in this group of epilepsy patients. The webcast will include presentations from renowned Key Opinion Leaders (KOLs) in epilepsy research, as well as an overview of the Company’s BREAKTHROUGH study, an open-label Phase 2 clinical trial evaluating the safety, tolerability, and efficacy of BMB-101 in adult patients...

Foremost Clean Energy Announces National Marketing Campaign

Written by Customer Service on April 28, 2025. Posted in Public Companies.

VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) — Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”) is pleased to announce the launch of an unprecedented multi-platform investor awareness campaign designed to educate millions of North American retail and institutional investors by combining premium, multi-level media channels. This comprehensive initiative blends premium broadcast media, targeted digital dissemination, and institutional outreach to articulate three fundamental truths: (1) the irreplaceable role of base load nuclear energy in the clean energy transition and as a key source of energy for data processing, including for Artificial Intelligence (AI), which is expected to drive future increases to demand for uranium to fuel nuclear reactors (2) Canada’s strategic advantage...

Colabor Announces the Date of Its First Quarter 2025 Results Conference Call

Written by Customer Service on April 28, 2025. Posted in Public Companies.

SAINT-BRUNO-DE-MONTARVILLE, Quebec, April 28, 2025 (GLOBE NEWSWIRE) — Colabor Group Inc. (TSX: GCL) (“Colabor” or the “Company”) will release its results for the first quarter ended March 22, 2025, after market close on Thursday, May 1, 2025. A conference call to discuss these results will be held on Friday, May 2, 2025 at 9:30 a.m. (Eastern Time). Conference Call: A live broadcast of the conference call will be available on the Company’s website, in the Investors section under Events and presentations. To participate (professional investment community only) or to listen to the live conference call:Date: Friday, May 2, 2025Time: 9:30 a.m. (Eastern Time) Conference Number: 41794North-American participants dial toll-free: 1-800-990-4777International and local dial-in: 1-289-819-1299 or 1-514-400-3794You can...

Volaris Reports Financial Results for the First Quarter 2025

Written by Customer Service on April 28, 2025. Posted in Earnings Releases And Operating Results.

MEXICO CITY, April 28, 2025 (GLOBE NEWSWIRE) — Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS and BMV: VOLAR) (“Volaris” or “the Company”), the ultra-low-cost carrier (ULCC) serving Mexico, the United States, Central and South America, today reports its unaudited financial results for the first quarter 20251. First Quarter 2025 Highlights(All figures are reported in U.S. dollars and compared to 1Q 2024 unless otherwise noted)Net loss of $51 million. Loss per American Depositary Shares (ADS) of $45 cents. Total operating revenues of $678 million, a 12% decrease. Total revenue per available seat mile (TRASM) decreased 17% to $7.76 cents. Available seat miles (ASMs) increased by 6% to 8.7 billion. Total operating expenses of $688 million, representing 101% of total operating revenue. Total operating expenses...

Day: April 28, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals